Recruiting
Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.
NCT07243002
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Novartis Investigative Site London, United Kingdom